Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Safinamida, cujo nome químico é (S) -2- [4- (3-fluorobenziloxi) benzilamino] propionamida metanossulfonato, é um medicamento anti-Parkinson desenvolvido pela Newron Pharmaceuticals, atualmente em fase III de pesquisa clínica. Clinicamente, foi demonstrado que este medicamento pode melhorar a função motora e cognitiva dos pacientes com doença de Parkinson, prevenir a discinesia dos pacientes e ter boa tolerância.
Grupo de Produto : Intermediários de API > Safinamida mesilato intermediário
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.